Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta-thalassemia and pulmonary function.

G Piatti1, L Allegra, U Ambrosetti

  • 1Ospedale Maggiore di Milano, Pad. Litta, via F. Sforza 35, Milan, Italy.

Haematologica
|September 8, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Night shift work and breast cancer risk in healthcare workers: a systematic review and meta-analysis.

Occupational medicine (Oxford, England)·2026
Same author

Improvement of psoriasis following initiation of biologic therapy is associated with lower risk of developing psoriatic arthritis: A single-center, retrospective, cohort study.

Journal of the American Academy of Dermatology·2025
Same author

Occupational asbestos exposure and ovarian cancer: updated systematic review.

Occupational medicine (Oxford, England)·2023
Same author

Cardiopulmonary testing in adult patients with β-thalassemia major in comparison to healthy subjects.

Annals of hematology·2022
Same author

Selective delivery of pentamidine toward cancer cells by self-assembled nanoparticles.

International journal of pharmaceutics·2022
Same author

Improved isolation of carbapenem-resistant Enterobacterales on selective-differential media extending the incubation time: an approach to strengthen the antimicrobial surveillance from rectal swabs.

The Journal of hospital infection·2022
Same journal

Emapalumab and eltrombopag rescue for prolonged immune effector cell-associated hemophagocytic syndrome after CAR T-cell therapy in multiple myeloma.

Haematologica·2026
Same journal

Incidence and predictors of recurrent venous thromboembolism after isolated distal deep vein thrombosis: a <i>post-hoc</i> analysis of the RIDTS trial.

Haematologica·2026
Same journal

Philadelphia positive T-acute lymphoblastic leukemia: a Mayo Clinic series.

Haematologica·2026
Same journal

Long-term follow-up of oral decitabine/cedazuridine plus venetoclax for older or unfit patients with newly diagnosed acute myeloid leukemia.

Haematologica·2026
Same journal

Reframing leukemia-niche interactions: the emerging role of the marrow adipocyte lineage.

Haematologica·2026
Same journal

A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin lymphoma.

Haematologica·2026
See all related articles

Beta-thalassemia major patients show reduced lung function, indicating restrictive lung disease. Beta-thalassemia intermedia patients maintain normal lung function, suggesting disease type impacts pulmonary health.

Area of Science:

  • Hematology
  • Pulmonology
  • Internal Medicine

Background:

  • Improved survival in beta-thalassemia major and intermedia necessitates understanding long-term sequelae.
  • While organ damage from hemosiderosis is known, lung damage pathophysiology remains unclear.
  • This study investigates lung function in beta-thalassemia patients.

Purpose of the Study:

  • To assess lung function changes in patients with beta-thalassemia major and intermedia.
  • To identify potential causes of lung dysfunction in beta-thalassemia.
  • To differentiate pulmonary impact between beta-thalassemia major and intermedia.

Main Methods:

  • Evaluated 32 patients (19 major, 13 intermedia) using pulmonary function tests, CO diffusion, and arterial blood gas analysis.

Related Experiment Videos

  • Tests were conducted 24 hours before transfusion or during stable hematologic condition.
  • Echocardiography assessed cardiac function via ejection fraction.

    • Main Results:

    • No clinical signs of pulmonary dysfunction were observed.
    • Beta-thalassemia major patients exhibited reduced lung function (TLC, FVC, FEV1, RV), consistent with restrictive lung disease.
    • Beta-thalassemia intermedia patients showed preserved pulmonary function; CO diffusion approached lower normal limits in some.
    • Pulmonary abnormalities were not linked to congestive heart failure.

    Conclusions:

    • Iron deposition from transfusions may cause lung alterations, even with good chelation.
    • Multiple mechanisms likely contribute to lung damage in beta-thalassemia.
    • Lung function is significantly impacted in beta-thalassemia major but preserved in intermedia.